Nasdaq (NASDAQ) · Energy
NCS Multistage Holdings, Inc. NCSM
SpeculativeScore band: 30–40
The thesis, in one sentence
This stock was delisted after merging into a larger oilfield-services company, converting each share into acquirer stock or a cash-and-stock mix, so there is no longer a market price against which to measure a margin of safety.
Written for this site in plain English, without figures. The arithmetic is in the full report.
The thesis is from the deep report of 2026-08-18; the verdict badge reflects the latest scoring of 2026-09-11.
Key risks
- No market price remains against which to measure a margin of safety
- The investment case now depends on the acquirer, not this entity
- Merger consideration mixes stock and cash rather than one clean price
What would change the verdict
- A definitive market price for the successor would need to be tracked instead
- Share count in the combined entity rises through new issuance
- Debt relative to equity in the combined entity rises materially
- Operating margin in the combined entity improves for two consecutive quarters
Read it yourself
Step five of the method is the reader's: open the latest annual or quarterly report and read it before acting on anything here. A score is a summary, and a summary is not understanding.
Next report expected 2026-10-28. The deep report was written against the filings available on 2026-08-18; anything published since is not in it.
DCF valuation range
range of the DCF modelsbase casetoday's price
Valuation range, shape only. Figures in the full version.
Monte Carlo outcome shape
scenarios below today's pricescenarios above today's pricetoday's price
Distribution of simulated outcomes around today's price. Bar heights only; the scale and the percentiles are in the full version.
Where the money goes
Last four reported quarters, 2025-09 → 2026-06, in USD. Filings data as gathered on 2026-09-11. Figures rounded to three significant digits.
Chapter one: Executive summary (1 page: thesis, estimated value, verdict)
NCS Multistage Holdings, Inc. (NASDAQ: NCSM) — deep-value analysis
Analysis date: August 18, 2026 · Reference price: … · Market cap: … (2.624 mil. shares outstanding) · Sector: Oilfield Services / Well Completion Equipment Primary sources: 10-K FY2025 (filed 05.03.2026), 10-K FY2024/FY2023/FY2022, 10-Q Q1 2026 (04.30.2026), 10-Q Q2 2026 (07.31.2026), 10-Q Q3 2025, DEF 14A (04.02.2026), 8-K/425 Weatherford merger (06.02.2026). All figures in USD thousands unless specified.
Executive summary (1 page: thesis, estimated value, verdict)
NCS Multistage is no longer, as of this analysis, a company you can value as an independent business. On May 31, 2026, the board signed a merger agreement with Weatherford International plc, and the majority shareholder — Advent International-affiliated funds, with 56.3% of shares (DEF 14A, 04.02.2026) — approved the transaction by written consent the same day. There's no longer a minority shareholder vote; there was no public market check. Each NCSM share converts, at the holder's election, into 0.5537 Weatherford common shares — a ratio which, quoted verbatim from the June 2, 2026 8-K, "is not subject to any cap or proration" — or a mixed alternative (0.2392 shares + cash equivalent to 0.1371 shares, i.e. 0.3763 equivalent-shares, 32% less). Anyone who elects nothing automatically receives the stock alternative. Therefore the transaction's real value is 0.5537 × the WFRD price.
At WFRD … (the reference close), that means …/NCSM share. NCSM's price of … is 0.8% below parity. The market is already trading NCSM as a synthetic instrument on Weatherford, not as a business. Any deep-value thesis must answer a single question: if the deal falls through, what is the remaining company worth?
The answer is significantly less than … The FCF bridge (the valuation chapter) gives a flow to the NCSM shareholder of … TTM and … in FY2025 — not the … the mechanical CFO − capex formula gives, because at NCS two real leaks don't show up in capex: finance-lease principal (…/yr, with which the company actually buys its fleet) and distributions to the partner in the 50/50 Repeat Precision joint venture. Normalized for merger fees (… in H1 2026, non-recurring) and for stock compensation settled in equity (…/yr, a real dilution cost), the owner-earnings base for the DCF is …
Triangulating five models gives a brutally wide range: from … MOS (Greenwald earnings power value, starting from the uncomfortable fact that cumulative 2021–2025 operating profit was +… over five years, i.e. zero) to … (an optimistic DCF with a cyclical recovery). The median of the five models is …. The Monte Carlo simulation on the base DCF (20,000 scenarios) gives a median intrinsic value of … and an undervaluation probability of …% — but that model starts from owner earnings of …, and the 25th percentile is already negative.
The divergence between models isn't noise: it's the thesis itself. The DCF says "undervalued" because it extrapolates a cash flow that over the last two years has been inflated by three things that aren't the business: patent-licensing income (… in 2025, … in 2024, below the operating line), Repeat Precision's profit (a 50% JV, which in H1 2026 produced … net profit while the rest of NCS lost …), and the release of the deferred-tax-asset valuation allowance (a … tax benefit in 2025, of which … non-cash). The EPV says "overvalued" because it looks at what the operation itself produces: almost nothing.
Verdict: DO NOT BUY at … Not because the business is fraudulently bad, but because at this price you're not buying the business — you're buying 0.5537 Weatherford shares at a 0.8% discount and taking on the risk of being left with a company that, standalone, is worth between … and … per conservative models. The risk/reward ratio is asymmetric in the wrong direction: you gain 0.8% if everything goes well, you lose 25… if the deal falls through (and, if it falls through, it likely did so on weak-market grounds, i.e. exactly when WFRD is also down). The only way the position makes sense is as a deliberate proxy on Weatherford — and then you buy WFRD directly, without the merger's execution risk and without the … Canadian tax reassessment hanging over NCS.
Figures were removed from this excerpt. The full report opens free for five tickers a week — see what's open now.
Full report contents
- Executive summary (1 page: thesis, estimated value, verdict)
- 🔒 The business and the moat (how it makes money, competitive advantage, durability) (Available in the full report)
- 🔒 Management and capital allocation (track record, buybacks/dividends/acquisitions, skin in the game) (Available in the full report)
- 🔒 What changed over the last 4 quarters (balance sheet item by item from the data pack, margins, cash conversion — explaining EVERY large variation) (Available in the full report)
- 🔒 Balance sheet analysis — Quality of Earnings (Thornton O'Glove method) (Available in the full report)
- 🔒 CEO profile — Outsider traits (William Thorndike method) (Available in the full report)
- 🔒 Accounting red flags (accruals, dilution, one-offs, accounting policy changes) (Available in the full report)
- 🔒 Triangulated valuation (conservative DCF with explicit assumptions + earnings power value + 5-year historical multiples + Monte Carlo from step 5; a range, not a point) (Available in the full report)
- 🔒 Pre-mortem (why the thesis could be wrong — 3 concrete scenarios) (Available in the full report)
- 🔒 Verdict compared to the tracker's GBL score (convergence/divergence and why) (Available in the full report)
Evaluation history
| Date | Verdict |
|---|---|
| 2026-08-18 | Speculative |
| 2026-09-06 | Speculative |
| 2026-09-11 | Speculative |
Want the rest of this report?
Subscribe to get one full deep report a week by email, the day before it opens on the site.